Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have been assigned an average recommendation of “Strong Sell” from the five research firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation and two have assigned a hold recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $17.60.
AFYA has been the topic of several research reports. Wall Street Zen lowered shares of Afya from a “buy” rating to a “hold” rating in a research report on Friday, June 6th. Morgan Stanley downgraded Afya from an “equal weight” rating to an “underweight” rating and cut their price target for the stock from $19.00 to $17.00 in a research note on Tuesday, March 11th.
View Our Latest Stock Analysis on Afya
Institutional Inflows and Outflows
Afya Stock Performance
Shares of AFYA opened at $17.99 on Friday. The stock has a 50 day moving average of $18.39 and a 200 day moving average of $17.15. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 14.51, a PEG ratio of 0.29 and a beta of 0.60. Afya has a 12 month low of $14.52 and a 12 month high of $19.90. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Recommended Stories
- Five stocks we like better than Afya
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Is Consumer Discretionary a Dead End? These 3 Stocks Say No
- How to Invest in Small Cap Stocks
- Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile
- Stock Market Upgrades: What Are They?
- Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.